categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
gurjeet singh
Thought Leaders in Artificial Intelligence: Gurjeet Singh, Co-Founder and Chairman of Ayasdi (Part 5)
Sramana Mitra: Do you want to talk about the healthcare use case a bit? Gurjeet Singh: Similar to financial services, we build applications that solve problems end-to-end. The first application in healthcare that we sell to both healthcare payers and providers is the application that detects and hopes to mitigate the problem of clinical radiation.
Thought Leaders in Artificial Intelligence: Gurjeet Singh, Co-Founder and Chairman of Ayasdi (Part 4)
Sramana Mitra: By rolling out your software in a risk operation that has such large numbers of manual labor, how many people can you replace with the software? Gurjeet Singh: At this point, the banks are not talking about replacing people. They’re worried about capturing risk. They are more interested in making sure that they
Thought Leaders in Artificial Intelligence: Gurjeet Singh, Co-Founder and Chairman of Ayasdi (Part 3)
Sramana Mitra: How were customers finding you? Gurjeet Singh: Just through media. The launch in January was such a huge event. There was a lot of media and buzz around it. It felt like it was a pretty successful time, and it definitely gave us a false sense of complacency. What we realized was while
Thought Leaders in Artificial Intelligence: Gurjeet Singh, Co-Founder and Chairman of Ayasdi (Part 2)
Sramana Mitra: So, grants and some consulting projects kept you going for a while. What happened next? Gurjeet Singh: Yes, those were very lean days. My co-founders had done well enough that they could easily live without a salary for a long time. I was the only one, as the immigrant, who had to be
Thought Leaders in Artificial Intelligence: Gurjeet Singh, Co-Founder and Chairman of Ayasdi (Part 1)
This is a very interesting conversation about technology from Stanford being commercialized in financial services and healthcare, addressing very specific use cases in risk and other domains. Sramana Mitra: Let’s start by introducing our audience to yourself as well as to Ayasdi. Gurjeet Singh: I’m one of the co-founders and Chairman of the Board at
